207_Combined course Presentations
Prodige/ACCORD 12/0450 trial
Staging :- Evaluated by TRUS and/or MRI
Centre policy
S
Capecitabine 800mg/m2
45 Gy CRT
N=598
Oxaliaplatin 50mg/m2 x 5
S
Centre policy
Capecitabine 800mg/m2 *
50.4Gy CRT
Primary end point- pCR 11% - 20% 85% power
Made with FlippingBook